SAN || News

Novel agent for papulopustular rosacea found safe, effective in phase III trials

Posted on: 23/03/2014 - 19:50

DENVER – Ivermectin 1% cream applied once daily was effective and safe in treating patients with moderate to severe papulopustular rosacea, based on data from a pair of phase III studies. Ivermectin...

Field of Interest: Dermatology

Type: News Item

VIDEO: Ivermectin shows promise for treating papulopustular rosacea

Posted on: 23/03/2014 - 18:40

DENVER – A limited number of safe and effective topical medications are currently available to treat chronic papulopustular (inflammatory) rosacea. In a <link...

Field of Interest: Dermatology

Type: News Item

‘Culture of Safety’ best defense against sharps injury

Posted on: 21/03/2014 - 18:10

DENVER – Of all the procedures and behaviors that place dermatologists at risk for occupational exposure, needlestick injuries rank at the top. According to 1999 data from the National Institute...

Field of Interest: Infectious diseases

Type: News Item

VIDEO: Allergy myths misdirect patients, physicians

Posted on: 14/03/2014 - 15:10

SAN DIEGO – Is there really such a thing as a hypoallergenic dog? (Bo Obama, we’re looking at you.) Can blood tests for sale on the Internet identify a child’s allergies? And must parents wait until...

Field of Interest: Gastroentero...

Type: News Item

VIDEO: Allergy myths misdirect patients, physicians

Posted on: 14/03/2014 - 15:10

Field of Interest: Dermatology

Type: News Item

VIDEO: Allergy myths misdirect patients, physicians

Posted on: 14/03/2014 - 15:10

Field of Interest: Rheumatology

Type: News Item

VIDEO: Sun protection myths debunked

Posted on: 13/03/2014 - 17:20

CHAMPIONSGATE, FLA. – Can you separate sun protection myths from facts for your patients? Misperceptions persist, but sunscreen remains a safe and effective tool to help protect the skin from...

Field of Interest: Dermatology

Type: News Item

FDA panel unanimously backs cobas HPV test as primary screening tool

Posted on: 13/03/2014 - 16:15

COLLEGE PARK, MD. – A Food and Drug Administration advisory panel has unanimously supported expanding the approval of the cobas human papilloma virus test to include its use as a first-line primary...

Field of Interest: Pulmonology

Type: News Item

FDA panel unanimously backs cobas HPV test as primary screening tool

Posted on: 13/03/2014 - 16:15

Field of Interest: Infectious diseases

Type: News Item

Nivolumab extends survival in advanced melanoma

Posted on: 12/03/2014 - 14:15

An immunomodulator that targets the PD-1 pathway effected sustained remission in 31% of patients who took it for advanced melanoma. Remission lasted a median of 2 years, with 1- and 2-year overall...

Field of Interest: Oncology

Type: News Item

Newsletters

Stay informed on our latest news!

You are here

Newsletters

Latest Newsletters